Komori
Other Disclosures2934J Frontier Co.,Ltd.Food

In its 14th year since launch, ‘Hokkoku no Megumi’ surpasses 5 million bags sold cumulatively, continuing to address customers’ knee concerns with proteoglycan derived from Hokkaido salmon

The group company’s Food with Function Claims product ‘Hokkoku no Megumi’ surpassed 5 million bags sold cumulatively since its launch in January 2013. The company will continue improving the product and services and expanding sales through customer engagement events and other initiatives.

Worth reading
56In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
5000000
Bags (cumulative sales, as of the end of June 2026)
Wording
Definitive
How definitive the wording is.

Announced details

Hokkoku no Megumi health supplement
Applicable field (uses covered by this announcement)

Relief of discomfort experienced by healthy middle-aged and older adults when walking and going up and down stairs due to discomfort in the knee joints

Launch dateJanuary 2013 (launch track record)
What the company reported numerically
Quantitative Effects

5 million bags sold cumulatively (as of the end of June 2026)

Usage history

5 million bags sold cumulatively (as of the end of June 2026)

Relationship between the counterparty and the company
J Frontier Co.,Ltd.2934
Relationship with the Company

株式会社ウェルヴィーナス is a group company of J Frontier Co.,Ltd.

Counterparty (name not disclosed)

株式会社ウェルヴィーナス: Shibuya-ku, Tokyo; Representative Director and President Hashimoto Shingo (橋本真吾); established in December 2010; develops and sells health foods, cosmetics and other products

Registration number and expiry date

Manufacturing-process Patent No. 6611968

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredHokkoku no Megumi health supplement
Counterparty overview株式会社ウェルヴィーナス: Shibuya-ku, Tokyo; Representative Director and President Hashimoto Shingo (橋本真吾); established in December 2010; develops and sells health foods, cosmetics and other products
Relationship with the Company株式会社ウェルヴィーナス is a group company of J Frontier Co.,Ltd.
Launch dateJanuary 2013 (launch track record)
Applicable areaRelief of discomfort experienced by healthy middle-aged and older adults when walking and going up and down stairs due to discomfort in the knee joints
Registration number and expiry dateManufacturing-process Patent No. 6611968
Quantitative Effects5 million bags sold cumulatively (as of the end of June 2026)
Usage history5 million bags sold cumulatively (as of the end of June 2026)
Items this document does not state (10)
CounterpartyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyLocationLocation scaleImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The cumulative sales reflect the results built up over many years as customers incorporated the product into their daily lives. Going forward, the company will use feedback obtained through customer interactions, interviews and roundtable discussions to improve its products and services and deliver them to more customers.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
In its 14th year since launch, ‘Hokkoku no Megumi’ surpasses 5 million bags sold cumulatively, continuing to address customers’ knee concerns with proteoglycan derived from Hokkaido salmon | J Frontier Co.,Ltd. (2934) timely disclosure | Komori